The C-terminal domain of σ A C170 (last 359-528 aa) gene was amplified from M. tuberculosis H37Rv genomic DNA and inserted at the KpnI-XhoI site of pCDF-1b for expressing His6-σ A C170; Spec R This study pET28b-6HisMtbσ A C112
The gene encoding the C-terminal domain of σ A containing the last 112 residues (417-528 aa) was amplified from pCDF-1b-6HisMtbσ A C170 and inserted into the NcoI-XhoI site of pET28b for expressing His6σ A C112. It was co-expressed with tagless WhiB1 for crystallization; Kan R This study pCDF-1b-6HisMtbσ A C170mutant (K513A, R515H, H516A, H516F, P517A, S518A or S520A)
A modification of pCDF-1b-6HisMtbσ A C170 by sitedirected mutagenesis for expressing His6-σ A C170 with a single mutation of either K513A, R515H, H516A, H516F, P517A, S518A or S520A; Spec R This study
pET19b-10HisMtbWhiB1
The full-length whiB1 gene was amplified from M. tuberculosis H37Rv genomic DNA and inserted into the NdeI-XhoI site of pET19b for expressing His10 tagged-WhiB1; Amp R This study pET19b-10HisMtbWhiB1-mutants (W3A, F17A, F18A, W49A or W60A) A modification of pET19b-10HisMtbWhiB1 by sitedirected mutagenesis for expressing His10-WhiB1 carrying a single mutation of either W3A, F17A, F18A, W49A or W60A; Amp R This study pET28b-MtbWhiB1
The full-length whiB1 gene was amplified from M. tuberculosis H37Rv genomic DNA and inserted into the NcoI-XhoI site of pET28b for expressing tagless WhiB1; Kan R a The reported distances are the average and the range of the shortest distances of the specified residues between the two copies of the WhiB1:σ A CTD complex molecules in an asymmetric unit. a The reported inter-atomic distances are the average and the range between the two copies of the WhiB1:σ A CTD complex molecules in an asymmetric unit, unless otherwise specified. b The interactions are only observed in one copy of the WhiB1:σ A CTD complex within the distance cutoff of 4.0 Å. Supplementary Figure 1 . Increasing amounts of the protein sample from the co-expression and affinity purification of His6-σ A C170 with WhiB1-W3A were used in Panel D to show the weak band of WhiB1-W3A. The band with an apparent molecular weight of ~15 kDa shown in Panels C and D resulted from partial degradation of His6-σ A C170, which is more significant with reduced complex formation by the WhiB1 mutants. The peptide identities of the partial degraded His6-σ A C170 and WhiB1-W3A were confirmed by mass spectrometry. Ni 2+ Sepharose High Performance resin (GE Healthcare Life Sciences) was used for affinity purification. Figure 6 . UV-Visible spectra of the WhiB1 proteins alone and in complex with His6-σ A C170. The intensity of the absorption peak around 410 nm is indicative of the occupancy of the [4Fe-4S] cluster in WhiB1. The absorption spectra were normalized at 280 nm based on the protein concentrations estimated by the Pierce Bradford Assay Kit. (A) His10-WhiB1 wildtype and mutant proteins expressed and purified from E. coli. By comparison to the wildtype protein, the His10-WhiB1-W49A mutants showed distinct features in the visible region and lower peak intensity around 410 nm of the absorption spectrum, indicating a lower occupancy of the [4Fe-4S] cluster. In contrast, the F17A, F18A and W60A mutations in WhiB1 showed no significant effect on the absorption spectra. (B) The tagless WhiB1 wildtype and mutant proteins co-expressed and purified with His6-σ A C170 from E. coli. The visible region of the absorption spectra for all the WhiB1 mutant proteins in complex with His6-σ A C170 are comparable to that for the WhiB1 wildtype protein alone, except for WhiB1-W3A, whose peak intensity around 410 nm is decreased to ~1/3 of the wildtype protein complex. The UV-Visible spectrum of His6-σ A C170 is shown as a reference. Fig. 5D . Lane 1, the reaction with the RNAP core enzyme alone as the negative control; Lane 2, the reaction with the RNAP holoenzyme (i.e., including σ A ) and without WhiB1; Lane 3, the reaction with the RNAP holoenzyme and 10 µM WhiB1; Lane 4, the forced abortive transcription from the rrnAP3 promoter with the RNAP holoenzyme alone as in Lane 2 but without ATP. 
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